UPDATE 3-Cardinal to buy J&J vascular technology unit Cordis for $1.9 bln

NEW YORK, March 2 (Reuters) – U.S. pharmaceutical and medical equipment maker Johnson & Johnson said on Monday it agreed to sell its Cordis vascular technology unit to Cardinal Health for $1.9 billion, completing its exit from the cardiovascular stent business.




Source: Technology Sector News

Leave a Reply

Your email address will not be published. Required fields are marked *

2 × five =